What is it about?

This is a case featuring supratherapeutic memantine use in catatonia in schizophrenia, which can be safe option with other first line (benzodiazepines) and second line (electroconvulsive therapy) options fail. There are no other reported cases of supratherapeutic memantine use prior to this.

Featured Image

Read the Original

This page is a summary of: Supratherapeutic Memantine for the Treatment of Catatonia in Schizophrenia: A Case Report and Discussion, Journal of Neuropsychiatry, August 2025, American Psychiatric Association,
DOI: 10.1176/appi.neuropsych.20250040.
You can read the full text:

Read

Contributors

The following have contributed to this page